Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides

Food and Chemical Toxicology

Volumn 49, Issue 1, 2011, Pages 61-69

  Zhang, Qian ^a   Piao, Xiang Lan ^b   Piao, Xiang Shu ^a   Lu, Ting ^a   Wang, Ding ^a   Kim, Sung Woo ^c  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b MINZU UNIVERSITY OF CHINA   (China)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Berberine; Coptis chinensis; Inflammatory cytokines; Nuclear factor kappa B; Reactive oxygen species; Toll like receptor 4

Indexed keywords

BERBERINE; COPTIS CHINENSIS EXTRACT; GLUTATHIONE PEROXIDASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; ILEUM; INTESTINE INJURY; INTESTINE VILLUS; MALE; NONHUMAN; RAT; SEPSIS;

ANIMALS; ANTIOXIDANTS; BERBERINE; COPTIS; ILEUM; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

COPTIS CHINENSIS; RATTUS;

EID: 78650261067     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.09.032     Document Type: Article

References (53)

1. Abreu M.T., Arnold E.T., Thomas L.S., Gonsky R., Zhou Y., Hu B., Arditi M. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J. Biol. Chem. 2002, 277:20431-20437.
2. Albuszies G., Brükner U.B. Antioxidant therapy in sepsis. Intens. Care Med. 2003, 29:1632-1636.
3. Asehnoune K., Strassheim D., Mitra S., Kim J.Y., Abraham E. Involvement of reactive oxygen species in toll-like receptor 4-dependent activation of NF-κB. J. Immunol. 2004, 172:2522-2529.
4. Blackwell T.S., Blackwell T.R., Holden E.P., Christman B.W., Christman J.W. In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J. Immunol. 1996, 157:1630-1637.
5. Chang C.K., Llanes S., Schumer W. Inhibitory effect of dimethyl sulfoxide on nuclear factor-[kappa]B activation and intercellular adhesion molecule 1 gene expression in septic rats. J. Surg. Res. 1999, 82:294-299.
6. Chiang Y.H., Jen L.N., Su H.Y., Lii C.K., Sheen L.Y., Liu C.T. Effects of garlic oil and two of its major organosulfur compounds, diallyl disulfide and diallyl trisulfide, on intestinal damage in rats injected with endotoxin. Toxicol. Appl. Pharm. 2006, 213:46-54.
7. China Pharmacopoeia Committee Chinese Pharmacopoeia 2005, Chemical Industry Press, Beijing, pp. 213-214. first ed.
8. China Pharmacopoeia Committee Chinese Pharmacopoeia Clinical Medication Information 2005, People's Medical Press, Beijing, pp. 572-573. first ed.
9. Clark J.A., Coopersmith C.M. Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock 2007, 28:384-393.
10. Cortas N.K., Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 1990, 36:1440-1443.
11. Cribbs S.K., Martin G.S. Expanding the global epidemiology of sepsis. Crit. Care Med. 2007, 35:2646-2648.
12. Dvořák Z., Vrzal R., Maurel P., Ulrichová J. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-κB in HeLa cells. Chem. Biol. Interact. 2006, 159:117-128.
13. Feng Y., Luo W.Q., Zhu S.Q. Explore new clinical application of Huanglian and corresponding compound prescriptions from their traditional use. China J. Chin. Mater. Med. 2008, 33:1221-1225.
14. Forman H.J., Torres M., Fukuto J. Redox signaling. Mol. Cell. Biochem. 2002, 234-235:49-62.
15. Gloire G., Legrand-Poels S., Piette J. NF-κB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 2006, 72:1493-1505.
16. Gong Y., Wang L., Wang H., Li T., Chen X. The expression of NF-κB, Ki-67 and MMP-9 in CCOT, DGCT and GCOC. Oral Oncol. 2009, 45:515-520.
17. Hafeman D.G., Sunde R.A., Hoekstra W.G. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J. Nutr. 1974, 104:580-587.
18. Hirano H., Tokuhira T., Yoshioka Y., Yokoi T., Shingu T. Analysis of gastric mucosus membrane-protective compounds in Coptidis rhizoma. Nat. Med. 2000, 54:209-212.
19. Hsiang C.Y., Wu S.L., Cheng S.E., Ho T.Y. Acetaldehyde-induced interleukin-1β and tumor necrosis factor-α production is inhibited by berberine through nuclear factor-κB signaling pathway in HepG2 cells. J. Biomed. Sci. 2005, 12:791-801.
20. Ishii K.J., Akira S. Toll-like receptors and sepsis. Curr. Infect. Dis. Rep. 2004, 6:361-366.
21. Jang M.H., Kim H.Y., Kang K.S., Yokozawa T., Park J.H. Hydroxyl radical scavenging activities of isoquinoline alkaloids isolated from Coptis chinensis. Arch. Pharm. Res. 2009, 32:341-345.
22. Jeong H.W., Hsu K.C., Lee J.W., Ham M., Huh J.Y., Shin H.J., Kim W.S., Kim J.B. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E955-E964.
23. Kobayashi Y., Yamashita Y., Fujii N., Takaboshi K., Kawakami T., Kawamura M., Mizukami T., Nakano H. Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes. Planta Med. 1995, 61:414-418.
24. Kuo C.L., Chi C.W., Liu T.Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 2004, 203:127-137.
25. Lee C.H., Chen J.C., Hsiang C.Y., Wu S.L., Wu H.C., Ho T.Y. Berberine suppresses inflammatory agents-induced interleukin-1β and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells. Pharmacol. Res. 2007, 56:193-201.
26. Lee D.U., Kang Y.J., Park M.K., Lee Y.S., Seo H.G., Kim T.S., Kim C.H., Chang K.C. Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-α, iNOS, and IL-12 production in LPS-stimulated macrophages. Life Sci. 2003, 73:1401-1412.
27. Lee H.J., Son D.H., Lee S.K., Lee J., Jun C.D., Jeon B.H., Lee S.K., Kim E.C. Extract of Coptidis rhizoma induces cytochrome-c dependent apoptosis in immortalized and malignant human oral keratinocytes. Phytother. Res. 2006, 20:773-779.
28. Lee S.J., Lim K.T. Glycoprotein isolated from Ulmus davidiana Nakai regulates expression of iNOS and COX-2 in vivo and in vitro. Food Chem. Toxicol. 2007, 45:990-1000.
29. Li F., Wang H.D., Lu D.X., Wang Y.P., Qi R.B., Fu Y.M., Li C.J. Neutral sulfate berberine modulates cytokine secretion and increases survival in endotoxemic mice. Acta Pharmacol. Sin. 2006, 27:1199-1205.
30. Liu S.F., Ye X., Malik A.B. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 1999, 100:1330-1337.
31. Liu Y., Han J., Huang J., Wang X., Wang F., Wang J. Dietary l-arginine supplementation improves intestinal function in weaned pigs after an Escherichia coli lipopolysaccharide challenge. Asian Austral. J. Anim. 2009, 22:1667-1675.
32. Macdonald J., Galley H.F., Webster N.R. Oxidative stress and gene expression in sepsis. Brit. J. Anaesth. 2003, 90:221-232.
33. Mercer D.W., Smith G.S., Cross J.M., Russell D.H., Chang L., Cacioppo J. Effects of lipopolysaccharide on intestinal injury: potential role of nitric oxide and lipid peroxidation. J. Surg. Res. 1996, 63:185-192.
34. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
35. Ozdemir D., Uysal N., Tugyan K., Gonenc S., Acikgoz O., Aksu I., Ozkan H. The effect of melatonin on endotoxemia-induced intestinal apoptosis and oxidative stress in infant rats. Intens. Care Med. 2007, 33:511-516.
36. Pan G.Y., Wang G.J., Liu X.D., Fawcett J.P., Xie Y.Y. The involvement of P-glycoprotein in berberine absorption. Pharmacol. Toxicol. 2002, 91:193-197.
37. Park H.S., Jung H.Y., Park E.Y., Kim J., Lee W.J., Bae Y.S. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-κB. J. Immunol. 2004, 173:3589-3593.
38. Pearl-Yafe M., Fabian I., Halperin D., Flatau E., Werber S., Shalit I. Interferon-γ and bacterial lipopolysaccharide act synergistically on human neutrophils enhancing interleukin-8, interleukin-1β, tumor necrosis factor-α, and interleukin-12 p70 secretion and phagocytosis via upregulation of toll-like receptor 4. Shock 2007, 27:226-231.
39. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2007, 22:659-661.
40. Ryan K.A., Smith M.F., Sanders M.K., Ernst P.B. Reactive oxygen and nitrogen species differentially regulate toll-like receptor 4-mediated activation of NF-κB and interleukin-8 expression. Infect. Immun. 2004, 72:2123-2130.
41. Sanlioglu S., Williams C.M., Samavati L., Butler N.S., Wang G., McCray P.B., Ritchie T.C., Hunninghake G.W., Zandi E., Engelhardt J.F. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-α secretion through IKK regulation of NF-κB. J. Biol. Chem. 2001, 276:30188-30198.
42. Schinella G.R., Tournier H.A., Prieto J.M., Mordujovich De Buschiazzo P., Ríos J.L. Antioxidant activity of anti-inflammatory plant extracts. Life Sci. 2002, 70:1023-1033.
43. Sheng M.P., Sun Q., Wang H. Studies on the intravenous pharmacokinetics and oral absorbtion of berberine HCl in beagle dogs. Sin. Pharmacol. Bull. 1993, 9:64-67.
44. Shirwaikar A., Shirwaikar A., Rajendran K., Punitha I.S.R. In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. Biol. Pharm. Bull. 2006, 29:1906-1910.
45. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988, 34:497-500.
46. Tang J., Feng Y., Tsao S., Wang N., Curtain R., Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J. Ethnopharmacol. 2009, 126:5-17.
47. Vrzal R., Zdařilová A., Dvořák J., Bláha L., Giesy J.P., Dvořák Z. Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: biphasic effect on CYP1A1. Biochem. Pharmacol. 2005, 70:925-936.
48. Wang X., Xing D., Wang W., Su H., Tao J., Du L. Pharmacokinetics of berberine in rat thalamus after intravenous administration of Coptidis rhizoma extract. Am. J. Chinese Med. 2005, 33:935-943.
49. Wu H., Liu L., Tan Q., Wang C., Guo M., Xie Y., Tang C. Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-κB cytokine pathway. J. Gastrointest. Surg. 2009, 13:983-993.
50. Ye X., Feng Y., Tong Y., Ng K.M., Tsao S., Lau G.K.K., Sze C., Zhang Y., Tang J., Shen J., Kobayashi S. Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced acute liver hepatotoxicity in rats. J. Ethnopharmacol. 2009, 124:130-136.
51. Yu S., Yu Y.L., Lu S.S., Liu L., Liu X.D. Pharmacokinetics of berberine, palmatine, coptisine, epiberberine and jatrorrhizine from Coptidis rhizoma in diabetic rat. J. China Pharmaceut. Univ. 2008, 39:526-529.
52. Zeng X., Zeng X. Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed. Chromatogr. 1999, 13:442-444.
53. Zhou H., Mineshita S. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J. Pharmacol. Exp. Ther. 2000, 294:822-829.